{
    "references": [
        {
            "bibentry": "Lee, JY, Kim, S, Kim, YT, Lim, MC, Lee, B, Jung, KW. Changes in ovarian cancer survival during the 20 years before the era of targeted therapy, BMC Cancer, 2018, 18, 601, PMID: 29843633",
            "process_entry": "True",
            "doi": "10.1186/s12885-018-4498-z",
            "pmid": "29843633",
            "pmcid": "PMC5975501",
            "xmlid": "B1"
        },
        {
            "bibentry": "Kehoe, S, Hook, J, Nankivell, M, Jayson, GC, Kitchener, H, Lopes, T. Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial, Lancet, 2015, 386, 249, 257, PMID: 26002111",
            "process_entry": "True",
            "doi": "10.1016/s0140-6736(14)62223-6",
            "pmid": "26002111",
            "xmlid": "B2"
        },
        {
            "bibentry": "Onda, T, Satoh, T, Saito, T, Kasamatsu, T, Nakanishi, T, Nakamura, K. Comparison of treatment invasiveness between upfront debulking surgery versus interval debulking surgery following neoadjuvant chemotherapy for stage III/IV ovarian, tubal, and peritoneal cancers in a phase III randomised trial: Japan Clinical Oncology Group Study JCOG0602, Eur J Cancer, 2016, 64, 22, 31, PMID: 27323348",
            "process_entry": "True",
            "doi": "10.1016/j.ejca.2016.05.017",
            "pmid": "27323348",
            "xmlid": "B3"
        },
        {
            "bibentry": "Vergote, I, Tropé, CG, Amant, F, Kristensen, GB, Ehlen, T, Johnson, N. Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer, N Engl J Med, 2010, 363, 943, 953, PMID: 20818904",
            "process_entry": "True",
            "doi": "10.1056/nejmoa0908806",
            "pmid": "20818904",
            "xmlid": "B4"
        },
        {
            "bibentry": "Moore, KN, Pignata, S. Trials in progress: IMagyn050/GOG 3015/ENGOT-OV39. A Phase III, multicenter, randomized study of atezolizumab versus placebo administered in combination with paclitaxel, carboplatin, and bevacizumab to patients with newly-diagnosed stage III or stage IV ovarian, fallopian tube, or primary peritoneal cancer, Int J Gynecol Cancer, 2019",
            "process_entry": "True",
            "xmlid": "B5"
        },
        {
            "bibentry": "Kim, HS, Kim, JY, Lee, YJ, Kim, SH, Lee, JY, Nam, EJ. Expression of programmed cell death ligand 1 and immune checkpoint markers in residual tumors after neoadjuvant chemotherapy for advanced high-grade serous ovarian cancer, Gynecol Oncol, 2018, 151, 414, 421, PMID: 30314669",
            "process_entry": "True",
            "doi": "10.1016/j.ygyno.2018.08.023",
            "pmid": "30314669",
            "xmlid": "B6"
        },
        {
            "bibentry": "Galluzzi, L, Buqué, A, Kepp, O, Zitvogel, L, Kroemer, G. Immunological effects of conventional chemotherapy and targeted anticancer agents, Cancer Cell, 2015, 28, 690, 714, PMID: 26678337",
            "process_entry": "True",
            "doi": "10.1016/j.ccell.2015.10.012",
            "pmid": "26678337",
            "xmlid": "B7"
        },
        {
            "bibentry": "Becker, DA, Thomas, ED, Gilbert, AL, Boone, JD, Straughn, JM, Jr, Huh, WK. Improved outcomes with dose-dense paclitaxel-based neoadjuvant chemotherapy in advanced epithelial ovarian carcinoma, Gynecol Oncol, 2016, 142, 25, 29, PMID: 27130405",
            "process_entry": "True",
            "doi": "10.1016/j.ygyno.2016.04.539",
            "pmid": "27130405",
            "xmlid": "B8"
        },
        {
            "bibentry": "Garcia, YG, Juan, AD, Mendiola, C, Barretina-Ginesta, MP, Prat, A, Santaballa, A. Phase II randomized trial of neoadjuvant (NA) chemotherapy (CT) with or without bevacizumab (Bev) in advanced epithelial ovarian cancer (EOC) (GEICO 1205/NOVA TRIAL), 2017 ASCO Annual Meeting, 2017 Jun 2, Chicago, IL, American Society of Clinical Oncology, 2017, Abstract 5508",
            "process_entry": "True",
            "xmlid": "B9"
        },
        {
            "bibentry": "Yoshihama, T, Nomura, H, Iwasa, N, Kataoka, F, Hashimoto, S, Nanki, Y. Efficacy and safety of dose-dense paclitaxel plus carboplatin as neoadjuvant chemotherapy for advanced ovarian, fallopian tube or peritoneal cancer, Jpn J Clin Oncol, 2017, 47, 1019, 1023, PMID: 28973541",
            "process_entry": "True",
            "doi": "10.1093/jjco/hyx118",
            "pmid": "28973541",
            "xmlid": "B10"
        }
    ],
    "localid": "MED-31576697",
    "doi": "10.3802/jgo.2019.30.e112",
    "pmid": "10.3802/jgo.2019.30.e112",
    "pmcid": "31576697",
    "curator": "BEE EuropeanPubMedCentralProcessor",
    "source_provider": "Europe PubMed Central",
    "source": "https://www.ebi.ac.uk/europepmc/webservices/rest/31576697/fullTextXML",
    "reference_pointers": [
        [
            {
                "n_rp": 0,
                "xref_id": "B1",
                "rp_string": "1",
                "rp_xpath": "/article/body/sec[1]/p[1]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),1,66)",
                "containers_title": [
                    "INTRODUCTION"
                ]
            }
        ],
        [
            {
                "n_rp": 1,
                "xref_id": "B2",
                "rp_string": "2",
                "rp_xpath": "/article/body/sec[1]/p[1]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),169,288)",
                "containers_title": [
                    "INTRODUCTION"
                ]
            }
        ],
        [
            {
                "n_rp": 2,
                "xref_id": "B3",
                "rp_string": "3",
                "rp_xpath": "/article/body/sec[1]/p[1]/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),169,288)",
                "containers_title": [
                    "INTRODUCTION"
                ]
            }
        ],
        [
            {
                "n_rp": 3,
                "xref_id": "B4",
                "rp_string": "4",
                "rp_xpath": "/article/body/sec[1]/p[1]/xref[4]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),169,288)",
                "containers_title": [
                    "INTRODUCTION"
                ]
            }
        ],
        [
            {
                "n_rp": 4,
                "xref_id": "B2",
                "rp_string": "2",
                "rp_xpath": "/article/body/sec[1]/p[1]/xref[5]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),769,155)",
                "containers_title": [
                    "INTRODUCTION"
                ]
            }
        ],
        [
            {
                "n_rp": 5,
                "xref_id": "B4",
                "rp_string": "4",
                "rp_xpath": "/article/body/sec[1]/p[1]/xref[6]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[1]),769,155)",
                "containers_title": [
                    "INTRODUCTION"
                ]
            }
        ],
        [
            {
                "n_rp": 6,
                "xref_id": "B5",
                "rp_string": "5",
                "rp_xpath": "/article/body/sec[1]/p[2]/xref",
                "context_xpath": "substring(string(/article/body/sec[1]/p[2]),431,238)",
                "containers_title": [
                    "INTRODUCTION"
                ]
            }
        ],
        [
            {
                "n_rp": 7,
                "xref_id": "B6",
                "rp_string": "6",
                "rp_xpath": "/article/body/sec[1]/p[3]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[3]),212,136)",
                "containers_title": [
                    "INTRODUCTION"
                ]
            }
        ],
        [
            {
                "n_rp": 8,
                "xref_id": "B7",
                "rp_string": "7",
                "rp_xpath": "/article/body/sec[1]/p[3]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[1]/p[3]),1279,140)",
                "containers_title": [
                    "INTRODUCTION"
                ]
            }
        ],
        [
            {
                "n_rp": 9,
                "xref_id": "B8",
                "rp_string": "8",
                "rp_xpath": "/article/body/sec[5]/sec/sec[1]/p[2]/xref[1]",
                "context_xpath": "substring(string(/article/body/sec[5]/sec/sec[1]/p[2]),1,231)",
                "containers_title": [
                    "TREATMENT",
                    "1. Treatment arm",
                    "Safety run-in phase"
                ]
            }
        ],
        [
            {
                "n_rp": 10,
                "xref_id": "B9",
                "rp_string": "9",
                "rp_xpath": "/article/body/sec[5]/sec/sec[1]/p[2]/xref[2]",
                "context_xpath": "substring(string(/article/body/sec[5]/sec/sec[1]/p[2]),1,231)",
                "containers_title": [
                    "TREATMENT",
                    "1. Treatment arm",
                    "Safety run-in phase"
                ]
            }
        ],
        [
            {
                "n_rp": 11,
                "xref_id": "B10",
                "rp_string": "10",
                "rp_xpath": "/article/body/sec[5]/sec/sec[1]/p[2]/xref[3]",
                "context_xpath": "substring(string(/article/body/sec[5]/sec/sec[1]/p[2]),1,231)",
                "containers_title": [
                    "TREATMENT",
                    "1. Treatment arm",
                    "Safety run-in phase"
                ]
            }
        ]
    ]
}